Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure

Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction

European Journal of Heart Failure ◽

10.1002/ejhf.1724 ◽

2020 ◽

Vol 22 (8) ◽

pp. 1402-1411 ◽

Cited By ~ 5

Author(s):

Patrick Rossignol ◽

Kevin Duarte ◽

Nicolas Girerd ◽

Moez Karoui ◽

John J.V. McMurray ◽

...

Keyword(s):

Heart Failure ◽

Cardiovascular Risk ◽

Receptor Antagonist ◽

Left Ventricular Dysfunction ◽

Serum Potassium ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure

Circulation Cardiovascular Quality and Outcomes ◽

10.1161/circoutcomes.116.002946 ◽

2017 ◽

Vol 10 (1) ◽

Cited By ~ 12

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

High Risk ◽

Receptor Antagonist ◽

Antagonist Therapy ◽

Therapy Initiation ◽

Patients With Heart Failure ◽

Risk Patients

Epithelial Sodium Channel Genotype Is Associated with Elevated Potassium among Patients with Heart Failure Taking a Mineralocorticoid Receptor Antagonist

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2013.06.185 ◽

2013 ◽

Vol 19 (8) ◽

pp. S56

Author(s):

Alexandra Goncharenko ◽

Andrew Kadlec ◽

Adam Bress ◽

Shitalben Patel ◽

Orly Vardeny ◽

...

Keyword(s):

Heart Failure ◽

Sodium Channel ◽

Receptor Antagonist ◽

Epithelial Sodium Channel ◽

Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure

Journal of Cardiology ◽

10.1016/j.jjcc.2010.11.006 ◽

2011 ◽

Vol 57 (2) ◽

pp. 208-214 ◽

Cited By ~ 12

Author(s):

Masayasu Kimura ◽

Hiroshi Ogawa ◽

Takatoshi Wakeyama ◽

Akira Takaki ◽

Takahiro Iwami ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Guideline Concordance of Testing for Hyperkalemia and Kidney Dysfunction During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

Circulation Heart Failure ◽

10.1161/circheartfailure.113.000709 ◽

2014 ◽

Vol 7 (1) ◽

pp. 43-50 ◽

Cited By ~ 13

Author(s):

Larry A. Allen ◽

Susan M. Shetterly ◽

Pamela N. Peterson ◽

Jerry H. Gurwitz ◽

David H. Smith ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Kidney Dysfunction ◽

Antagonist Therapy ◽

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy

Circulation Heart Failure ◽

10.1161/circheartfailure.113.000792 ◽

2014 ◽

Vol 7 (1) ◽

pp. 51-58 ◽

Cited By ~ 131

Author(s):

Patrick Rossignol ◽

Daniela Dobre ◽

John J.V. McMurray ◽

Karl Swedberg ◽

Henry Krum ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Receptor Antagonist ◽

Medical Therapy ◽

Prognostic Significance ◽

Optimal Medical Therapy ◽

Worsening Renal Function ◽

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

JAMA ◽

10.1001/jama.2015.11904 ◽

2015 ◽

Vol 314 (18) ◽

pp. 1973 ◽

Cited By ~ 40

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Laboratory Monitoring ◽

Antagonist Therapy ◽

Laboratory Monitoring after Inpatient and Outpatient Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients with Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2016.06.087 ◽

2016 ◽

Vol 22 (8) ◽

pp. S26

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

Receptor Antagonist ◽

Laboratory Monitoring ◽

Antagonist Therapy ◽

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction

Circulation Reports ◽

10.1253/circrep.cr-21-0115 ◽

2021 ◽

Author(s):

Teruhiko Imamura ◽

Akira Oshima ◽

Nikhil Narang ◽

Koichiro Kinugawa

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Antagonist ◽

Preserved Ejection Fraction ◽

Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia

Internal Medicine ◽

10.2169/internalmedicine.6704-20 ◽

2021 ◽

Vol 60 (13) ◽

pp. 2093-2095

Author(s):

Teruhiko Imamura ◽

Akira Oshima ◽

Nikhil Narang ◽

Ryuichi Ushijima ◽

Yohei Ueno ◽

...

Keyword(s):

Heart Failure ◽

Combination Therapy ◽

Receptor Antagonist ◽

Sodium Zirconium ◽

Patients With Heart Failure ◽

Sodium Zirconium Cyclosilicate